OOIR: Observatory of International Research

Papers

(The TQCC of International Clinical Psychopharmacology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	39
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	29
The role of personality traits in following quarantine orders during the COVID-19 pandemic	20
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	19
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis	17
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	16
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	16
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	16
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	16
Open issues in bipolar and antipsychotic treatments	14
Clinical specificity profile for novel rapid acting antidepressant drugs	14
Preliminary evidence that blood extracellular nicotinamide phosphoribosyltransferase increases with antidepressant response to chronotherapeutics and to monoaminergic drugs	13
Antipsychotic polypharmacy in Japanese outpatients with schizophrenia: prevalence and sex- and age-related patterns	12
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	12
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	12
Managing depression in the elderly: real-world clinical considerations and perspectives	12
Assessing treatment adherence in psychiatry: a comparison of clinical judgment and therapeutic drug monitoring in acute care	12
Debated issues in major psychoses	11
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	11
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	11
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	11
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	11
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	10
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	10
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	10

Transcranial direct current stimulation and cognitive modifiability in obsessive compulsive disorder: a reaction to recent findings by Pellegrini et al.	10
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	10
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	10
The Gordian knot of the immune-redox systems’ interactions in psychosis	10
Addressing the challenge of treatment adherence in major depressive disorder in different settings	10
Differentiating aspects of oral and long-acting injectable antipsychotic drugs for tailoring the therapy of schizophrenia in clinical practice: a narrative review	9
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons	9
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	9
Elevated liver transaminases among patients with psychiatric disorders	9
Modulating factors in mood disorders treatment	8
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	8
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	8
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	8
Innovation in psychopharmacology	8
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	8
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	8
Allergic reaction induced by subcutaneous administration of ketamine: a case report	8
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	8
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	7
Case report and systematic review of cerebellar vermis alterations in psychosis	7
The challenge of managing difficult to treat psychiatric conditions	7
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	7
Manic episode in a patient with pancreatic adenocarcinoma: a case report	7
Advances in the treatment of depression	7
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	7
Innovative pharmacotherapy for mood disorders: safety, cardiometabolic burden, and real-world implementation	7
Interplay of environmental and clinical factors in psychiatric disorders	7
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	7
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	7
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	7